In vitro- forsøg viser, at bortezomib er en svag hæmmer af cytokrom P450 (CYP) - isozymer 1A2, 2C9, 2C19, 2D6 og 3A4.
In vitro studies indicate that bortezomib is a weak inhibitor of the cytochrome P450 (CYP) isozymes 1A2, 2C9, 2C19, 2D6 and 3A4.